RLMD

Relmada TherapeuticsC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-17

View Chart

RSI (14)

27.6

Oversold

MACD Hist

-0.11

Bearish

ATR (14)

0.41

Normal

Vol Z (20)

0.20

Normal

RET 20D

-22.1%

Negative

Dist 52W High

-33.3%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-07-17

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Mixed trend (SMAs not aligned)

Momentum

Negative momentum · 20D -22.1% · 60D -25.8%

RSI / MACD

RSI 27.6 (Oversold) · MACD hist -0.11

Volatility

Volatility normal (Z 0.20)

SMA20

6.41

SMA50

6.68

SMA200

5.06

EMA12

6.11

EMA26

6.35

BB Upper

7.25

BB Mid

6.41

BB Lower

5.57

RET 5D

-18.8%

RET 20D

-22.1%

RET 60D

-25.8%

RET 120D

+32.0%

As of 2026-07-17 • Updated nightlySource: Internal modelMethodology